SLC5A2 and chronic kidney disease: However, the observation that SGLT2 inhibitors lower BP even in more advanced CKD and on top of diuretics when the impact of SGLT2 inhibition on urinary volume, glucose and salt excretion is modest would rather indicate that natriuresis and osmotic diuresis induced by glycosuria are not unique mechanisms leading to the decrease in BP.